These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21851401)

  • 1. Why are some dialysis patients chronically hypotensive in the absence of heart disease and volume depletion?
    Palmer BF
    Semin Dial; 2011; 24(4):404-5. PubMed ID: 21851401
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypotension in end-stage renal disease: effect of postural change, exercise and angiotensin II infusion on blood pressure and plasma concentrations of angiotensin II, aldosterone and arginine vasopressin in hypotensive patients with chronic renal failure treated by dialysis.
    Sørensen SS; Danielsen H; Jespersen B; Pedersen EB
    Clin Nephrol; 1986 Dec; 26(6):288-96. PubMed ID: 3802595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EBPG guideline on haemodynamic instability.
    Kooman J; Basci A; Pizzarelli F; Canaud B; Haage P; Fouque D; Konner K; Martin-Malo A; Pedrini L; Tattersall J; Tordoir J; Vennegoor M; Wanner C; ter Wee P; Vanholder R
    Nephrol Dial Transplant; 2007 May; 22 Suppl 2():ii22-44. PubMed ID: 17507425
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cardiovascular disease in patients with 4 and 5 stage chronic kidney disease. Patient in chronic dialysis].
    Goicoechea MA
    Nefrologia; 2004; 24 Suppl(6):142-60, 187-235. PubMed ID: 15696904
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antihypertensive therapy in patients with 4 and 5 stage chronic kidney disease undergoing periodic dialysis].
    Goicoechea MA
    Nefrologia; 2004; 24 Suppl(6):161-71, 187-235. PubMed ID: 15696905
    [No Abstract]   [Full Text] [Related]  

  • 6. [Arterial hypotension in dialysis].
    Ureña P
    Nephrologie; 2001; 22(3):105-13. PubMed ID: 11436665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Autonomic dysfunction in chronic hypotension associated with uremia].
    Esforzado Armengol N; Cases Amenós A; Bono Illa M; López-Pedret J; Revert Torrellas L
    Med Clin (Barc); 1994 Mar; 102(8):285-9. PubMed ID: 8170225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How should chronic medical therapies be altered with the onset of end-stage renal disease and initiation of dialysis?
    Wyne KL; Fishbane S; Block GA; Warburton K; Berns JS; Neu AM; Warady BA
    Semin Dial; 2006; 19(1):8-24. PubMed ID: 16423174
    [No Abstract]   [Full Text] [Related]  

  • 9. Postsynaptic adrenergic unresponsiveness in hypotensive haemodialysis patients.
    Botey A; Gaya J; Montoliu J; Torras A; Rivera F; López-Pedret J; Revert L
    Proc Eur Dial Transplant Assoc; 1981; 18():586-91. PubMed ID: 7329986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic complications in hemodialysis: correlations with primary renal disease.
    Checheriţă IA; Turcu F; Dragomirescu RF; Ciocâlteu A
    Rom J Morphol Embryol; 2010; 51(1):21-6. PubMed ID: 20191115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of plasma catecholamine concentration in dialysis induced hypotensive patients.
    Oguchi K; Kawada Y; Shimoyama H; Suwata J; Saito H
    Nihon Jinzo Gakkai Shi; 1990 Mar; 32(3):291-5. PubMed ID: 2355665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of dialysis induced hypotension.
    Degoulet P; Réach I; Di Giulio S; Devriès C; Rouby JJ; Aimé F; Vonlanthen M
    Proc Eur Dial Transplant Assoc; 1981; 18():133-8. PubMed ID: 7329960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoreactive parathyroid hormone after volume change in normo- and hypotensive hemodialysis patients.
    Heintz B; Mann H; Kierdorf H; Königs F; Nelson K; Kirsten R; Heicke N; Wieland D; Gladziwa U; Sieberth HG
    Clin Nephrol; 1992 Mar; 37(3):140-4. PubMed ID: 1563118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversy in renal disease: dialysis-induced hypotension.
    Friedman EA
    Am J Kidney Dis; 1982 Sep; 2(2):289. PubMed ID: 7124727
    [No Abstract]   [Full Text] [Related]  

  • 16. Lipid management in chronic kidney disease, hemodialysis, and transplantation.
    Montague T; Murphy B
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):223-34. PubMed ID: 19217521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of encephalopathy by EEG frequency analysis in chronic dialysis patients.
    Kiley JE; Woodruff MW; Pratt KI
    Clin Nephrol; 1976 Jun; 5(6):245-50. PubMed ID: 776477
    [No Abstract]   [Full Text] [Related]  

  • 18. ESAs in dialysis patients: are you a hedgehog or a fox?
    Singh AK
    J Am Soc Nephrol; 2010 Apr; 21(4):543-6. PubMed ID: 20357173
    [No Abstract]   [Full Text] [Related]  

  • 19. Baroreceptor, not left ventricular, dysfunction is the cause of hemodialysis hypotension.
    Heber ME; Lahiri A; Thompson D; Raftery EB
    Clin Nephrol; 1989 Aug; 32(2):79-86. PubMed ID: 2766586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residual renal function and dialysis modality: is it really beneficial to preserve residual renal function in dialysis patients?
    Canaud B; Chenine L; Leray-Moragués H; Wiesen H; Tetta C
    Nephrology (Carlton); 2006 Aug; 11(4):292-6. PubMed ID: 16889567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.